The use of methylprednisolone pulse therapy in a severe case of HLA-B27 negative ankylosing spondylitis
Mercado, U.
Journal of Rheumatology 21(8): 1582-1583
1994
ISSN/ISBN: 0315-162X PMID: 7983673 Document Number: 432155
Document emailed within 1 workday
Related Documents
Grazio, S.; Grubisić, F.; Nemcić, T.; Matijević, V.; Skala, H. 2009: The reliability and validity of a Croatian version of the Bath Ankylosing Spondylitis Functional Index (BASFI) and Bath Ankylosing Spondylitis Disease Activity Index (BASDAI) in patients with ankylosing spondylitis Reumatizam 56(2): 63-76Rudge, S.R.; Treadwell, B.L. 1980: HLA B27 negative ankylosing spondylitis--a rare condition Australian and New Zealand Journal of Medicine 10(2): 227-229
Sieper, J.; Braun, J. 2002: New treatment strategies in ankylosing spondylitis: Proceedings of the Ankylosing Spondylitis Workshop, Berlin, Germany, 18-19 January 2002 Annals of the Rheumatic Diseases 61 Suppl. 3: Iii1-Iii2
Villa Alcázar, L.F.; de Buergo, M.; Rico Lenza, H.; Montull Fruitós, E. 1996: Aceclofenac is as safe and effective as tenoxicam in the treatment of ankylosing spondylitis: a 3 month multicenter comparative trial. Spanish Study Group on Aceclofenac in Ankylosing Spondylitis Journal of Rheumatology 23(7): 1194-1199
Kim, T.-J.; Shin, J.-H.; Sung, I.-H.; Lee, S.; Song, Y.; Kim, T.-H. 2016: Comparison on radiographic progression for 5 years between juvenile onset ankylosing spondylitis and adult onset ankylosing spondylitis: an observational study of the Korean SpondyloArthropathy Registry (OSKAR) data Clinical and Experimental Rheumatology 34(4): 668-672
Brandt, J.; Sieper, J.; Braun, J. 2002: Infliximab in the treatment of active and severe ankylosing spondylitis Clinical and Experimental Rheumatology 20(6 Suppl 28: S106-S110
Maksymowych, W.P.; Tao, S.; Vaile, J.; Suarez-Almazor, M.; Ramos-Remus, C.; Russell, A.S. 2000: LMP2 polymorphism is associated with extraspinal disease in HLA-B27 negative Caucasian and Mexican Mestizo patients with ankylosing spondylitis Journal of Rheumatology 27(1): 183-189
Ricci-Vitiani, L.; Vacca, A.; Potolicchio, I.; Scarpa, R.; Bitti, P.; Sebastiani, G.; Passiu, G.; Mathieu, A.; Sorrentino, R. 2000: MICA gene triplet repeat polymorphism in patients with HLA-B27 positive and negative ankylosing spondylitis from Sardinia Journal of Rheumatology 27(9): 2193-2197
Calin, A.; Garrett, S.; Whitelock, H.; Kennedy, L.G.; O'Hea, J.; Mallorie, P.; Jenkinson, T. 1994: A new approach to defining functional ability in ankylosing spondylitis: the development of the Bath Ankylosing Spondylitis Functional Index Journal of Rheumatology 21(12): 2281-2285
Miyamae, T.; Nakasima, S.; Imagawa, T.; Ito, S.; Katakura, S.; Tomono, N.; Mori, M.; Ibe, M.; Mitsuda, T.; Aihara, Y.; Yokota, S. 1999: Improvement of the maintenance therapy after methylprednisolone pulse therapy--effect of prednisolone combined with immunosuppressants Ryumachi 39(6): 829-835
Wei, J.C.-C.; Chan, T.W.; Lin, H.-S.; Huang, F.; Chou, C.-T. 2003: Thalidomide for severe refractory ankylosing spondylitis: a 6-month open-label trial Journal of Rheumatology 30(12): 2627-2631
Heldmann, F.; Brandt, J.; van der Horst-Bruinsma, I.E.; Landewe, R.; Sieper, J.; Burmester, G.R.; van den Bosch, F.; de Vlam, K.; Geusens, P.; Gaston, H.; Schewe, S.; Appelboom, T.; Emery, P.; Dougados, M.; Leirisalo-Repo, M.; Breban, M.; Listing, J.; Braun, J. 2011: The European ankylosing spondylitis infliximab cohort (EASIC): a European multicentre study of long term outcomes in patients with ankylosing spondylitis treated with infliximab Clinical and Experimental Rheumatology 29(4): 672-680
Beyer, J.M.; Hørslev-Petersen, K.; Helin, P. 1985: Methylprednisolone pulse therapy in Felty's syndrome Ugeskrift for Laeger 147(22): 1774-1775
Hrncír, Z.; Bradna, P.; Pidrman, V.; Tichý, M. 1988: Methylprednisolone pulse therapy in active polymyositis/dermatomyositis Vnitrni Lekarstvi 34(4): 376-383
Makitsubo, T.; Gotoh, S.; Sobue, G.; Sahashi, K.; Takahashi, A. 1985: Methylprednisolone pulse therapy for chronic relapsing polyradiculoneuropathy Rinsho Shinkeigaku 25(6): 733-737
Yoshimura, M.; Kida, H.; Saito, Y.; Takaeda, M.; Sugioka, G. 1991: Effects of methylprednisolone pulse therapy on progressive IgA nephropathy Nihon Jinzo Gakkai Shi 33(8): 761-768
Wallaert, B.; Ramon, P.; Fournier, E.C.; Hatron, P.Y.; Muir, J.F.; Tonnel, A.B.; Voisin, C. 1986: High-dose methylprednisolone pulse therapy in sarcoidosis European Journal of Respiratory Diseases 68(4): 256-262
Tanaka, J.; Matsuzaki, K.; Arai, H.; Nagai, T.; Matsumoto, Y.; Okada, S. 1994: Intermittent methylprednisolone pulse therapy for myasthenia gravis in childhood No to Hattatsu 26(1): 14-19
Mitić, I.; Fele, D.; Lenert, P.; Curić, S.; Vodopivec, S.; Bozić, D.; Sakac, V.; Djisalov, M.; Ilić, T.; Sebić, L.; Djurdjević-Mirković, T.; Tepavcević, P. 1996: Methylprednisolone pulse therapy in the early phases of lupus nephritis Srpski Arhiv Za Celokupno Lekarstvo 124(Suppl 1): 67-69
Bakker, C.; Hidding, A.; van der Linden, S.; van Doorslaer, E. 1994: Cost effectiveness of group physical therapy compared to individualized therapy for ankylosing spondylitis. A randomized controlled trial Journal of Rheumatology 21(2): 264-268